"We're particularly concerned about the health care area right now because obviously that's driving everything now," says Tennessee AG Herbert Slatery III. He and CRN CEO Steve Mister spoke with HBW Insight about regulation of the consumer health marketplace with FDA suspending inspections of facilities operated by businesses manufacturing and marketing products subject to its oversight.
Maintaining regulatory oversight of the US consumer health product marketplace during the novel coronavirus pandemic is putting in the spotlight two groups normally overshadowed by the work of federal agencies.
State agencies, particularly attorneys general offices, increased their monitoring of the consumer health market in anticipation that some businesses or...